IB
Impact BioMedical Inc.
IBO · AMEX
$0.49 -1.26% (-$0.01)
1M +16.28%
Market Cap $53.2M
P/E Ratio 67.47x
Div. Yield -
ROE 13.70%
Bulios Fair Price
$0.56
13.4% upside
Trenutna cena
$0.49
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica IBO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
10 /100
Expensive P/S 1,520.90x
P/B 4.94x
P/E 67.47x
Growth
0 /100
Declining Book val. growth 24.72%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 2,254.29%
Op. margin 14,562.90%
FCF margin 1,451.43%
Quality
58 /100
Average ROE 13.70%
ROA 4.71%
Asset turnover 0.00x
Debt
46 /100
Moderate Current ratio 0.16x
Int. coverage -5.89x
Debt/Equity 0.00x
Stability
1 /100
Unstable EPS volatility 3,173.45%
Profitable years 0
Beta 2.76x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Frank D. Heuszel
Employees
2
Headquarters
Houston